Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma

Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma

Changming Shao,1,* Chunfa Cheng,2,* Qinshu Shao,3 Bing Chen1 1Department of Vascular Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, People’s Republic of China; 2Department of Vascular Surgery, The First People’s Hospital o...

Full description

Bibliographic Details
Main Authors: Shao C, Cheng C, Shao Q, Chen B
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:International Journal of General Medicine
Subjects:
biglycan
stomach adenocarcinoma
high expression
immune infiltration
prognosis
Online Access:https://www.dovepress.com/identification-and-validation-of-biglycan-as-prognosis-and-therapy-mar-peer-reviewed-fulltext-article-IJGM

Internet

https://www.dovepress.com/identification-and-validation-of-biglycan-as-prognosis-and-therapy-mar-peer-reviewed-fulltext-article-IJGM

Similar Items